Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06590337 · ClinicalTrials.gov registry record · NA
Radicle Spark for Men 24: A Study of Health and Wellness Products on Sexual Health and Related Health Outcomes
A NA study of Sexual Satisfaction and Sexual Function, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 1,202
- Enrollment target
- 1
- Study location
NCT06590337: Completed NA study of Sexual Satisfaction and Sexual Function, sponsored by Radicle Science.
NCT06590337 is a NA study of Sexual Satisfaction and Sexual Function that has completed, run by Radicle Science. The registered enrollment target is 1,202 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06590337, a NA study of Sexual Satisfaction and Sexual Function, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,202 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on sexual health and related health outcomes
Primary Outcome
Difference between rates of change over time in sexual health score as assessed by Patient Reported Outcome Measurement System (PROMIS) Brief Profile Sexual Function and Satisfaction Survey \[male version consists of 4 health domains assessed only among participants with sexual activity in the 30 days prior: erectile function (score range = 2-10; higher scores indicate better erectile function), orgasm ability (score range = 1-5; higher scores indicate more ability), orgasm pleasure (score range
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Spark Placebo Control Form 1
- DIETARY_SUPPLEMENT Spark Active Study Product 1.1 Usage
- DIETARY_SUPPLEMENT Spark Placebo Control Form 2
- DIETARY_SUPPLEMENT Spark Active Study Product 2.1 Usage
Study Locations (1)
California
- Radicle Science, Inc - Del Mar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,202 participants |
| Start Date | 2024-10-07 |
| Est. Completion | 2025-01-01 |
| Phase | NA |
What the finished NCT06590337 record still lists
NCT06590337 is an interventional study that assigns participants to a tested intervention. Its 1,202 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% lower).
The record links to 2 conditions, with Sexual Satisfaction appearing as the primary indexed condition, and to 4 interventions - of which Spark Placebo Control Form 1 is the first listed.
NCT06590337 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06590337 about?
NCT06590337 is a clinical study titled "Radicle Spark for Men 24: A Study of Health and Wellness Products on Sexual Health and Related Health Outcomes". A randomized, double-blind, placebo-controlled study assessing the impact of health and wellness products on sexual health and related health outcomes
What is the current status of trial NCT06590337?
This trial is currently completed. It is a NA study. The enrollment target is 1,202 participants. The study started on 2024-10-07. Estimated completion is 2025-01-01.
What conditions does trial NCT06590337 study?
This clinical trial studies the following conditions: Sexual Satisfaction, Sexual Function.
What interventions are being tested in trial NCT06590337?
The interventions under investigation include: Spark Placebo Control Form 1 (DIETARY_SUPPLEMENT), Spark Active Study Product 1.1 Usage (DIETARY_SUPPLEMENT), Spark Placebo Control Form 2 (DIETARY_SUPPLEMENT), Spark Active Study Product 2.1 Usage (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06590337?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06590337 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06590337's enrollment target sits among peer trials
1,202 83rd of 2000 higher than 1,918 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07038785 · 1,204 participants
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
- NCT00477100 · 1,200 participants
Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- NCT01209000 · 1,200 participants
Nephrotic Syndrome Study Network
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI